Letter to the Editor: Doug Daniels, DVM, National HBPA President

After reading both the Bennet and Parkin article published in the Journal of the American Veterinary Medical Association entitled “Fifteen risk factors associated with sudden death in Thoroughbred racehorses in North America (2009-2021)” followed by the TDN analysis of that article, I have become increasingly aggravated over the last three weeks from the implied message portrayed by each.

The dramatic click-bait headline “Horses on Lasix at Increased Risk of Sudden Death” is unwarranted by the facts. When compared to the end of the article, one becomes more frustrated with the headline since the statement “further work is required to determine which, if any, clinical signs are potential indicators and, indeed, whether such a rare outcome could be reliably predicted” provides more realistic information than the sensationalistic title.

The authors of the JAVMA paper claim no conflict of interest, but it is funded by the Grayson Jockey Club Foundation, and “help in interpreting the Equine Injury Database” was provided by two long time employees of The Jockey Club. The Jockey Club has a long history of both funding Lasix research and also pressuring the recipients of this funding to interpret findings in a manner consistent with their long-held goal of the elimination of race-day administration of Lasix in American racing.

My first concern: “Sudden death” as defined in this paper deviates from accepted definitions. Exercise associated sudden death (EASD) is typically defined as acute death in an apparently healthy animal within one hour of exercise. Bennet and Parkin define sudden death as any horse that perished from non-musculoskeletal causes within 72 hours of racing, using five “codes” unique to the Jockey Club's Equine Injury Database (EID). Left undefined are the facts behind how a horse becomes classified into one of these categories.

Even the authors of the paper agree that “it would be reasonable to assume that several of the listed codes would not be accurate.” By the authors' own admission, using the EID with undefined codes that may have very different meanings in different jurisdictions result in conclusions that are not accurate.

More importantly, only 5.6% of the horses in this study started without Lasix. No effort is made on the part of the authors to determine what, if any, other factors are associated with not using Lasix. For example, they have determined that older horses are at higher risk of EASD, and this age group also consists of almost all horses who race on Lasix. The younger age group is the only age group where any number of horses can be found that race without Lasix.

The bigger question–completely ignored by the authors and their study funded by The Jockey Club–is why do horses in North America suffer EASD at a substantially lower rate than their counterparts in other parts of the world? In this paper, EASD (with all the caveats previously mentioned about its definition) occurs at a rate of 0.13/1,000 starts, which is close to 10% of the total deaths of racehorses. In Australia, this rate is more like 25% of the total, with a whopping 37% of these EASD a result of Exercise Induced Pulmonary Hemorrhage (EIPH). In a similar study in the United Kingdom, published by the same researchers in 2011, the rate of EASD was 0.3/1,000 starts.

Bennet and Parkin–of all people, being well familiar with the principles of epidemiology–should know full well that correlation does not equal causation. Yet, they offer in the conclusions of their paper that, “The association between furosemide and sudden death prompts further study to understand which biological processes could contribute to this result.”

What we do know however, is the presentation of information can greatly impact the public's reaction, as we have seen in these recent headlines. As presented in the TDN article and others on this topic, the odds ratio was presented as furosemide increases the risk of sudden death in horses by 62%. Yet as noted by James C Meyer DVM MSc in his recent paper, if stated as an increase in the absolute risk, it would be 0.005%. That figure as you can see does not have the sensationalized purposeful negative effect as saying 62%.

I implore the readers of this letter along with the authors of the JAVMA article to consider that the biological process is simply the passage of time. The most obvious association between Lasix and EASD is that the majority of horses not racing on Lasix during the time of their study were 2-year-olds.

We know there is a mountain of evidence demonstrating that Lasix mitigates EIPH. When combined with further evidence that EIPH remains the most common cause of EASD in other countries, it is beyond irresponsible to use this Jockey Club-funded study as the basis for any policy intended to safeguard the health and welfare of our racehorses.

Dr. Doug Daniels is president of the National HBPA and an equine practitioner who owns Virginia Equine. He owns and breeds Thoroughbred racehorses.

The post Letter to the Editor: Doug Daniels, DVM, National HBPA President appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

From Dust to Dust: Do “Terrible” Racetrack Barns Exacerbate EIPH?

For all the satchels of research dollars and reams of ink devoted to exercise-induced pulmonary hemorrhage (EIPH), it remains a topic Swiss cheese riddled with unknowns.

Which means that, as the sport continues to move away from Lasix as a crutch to manage the problem–especially when the federal Horseracing Integrity and Safety Act (HISA) outlines a timeframe for a total race-day Lasix ban–various lines of inquiry beg pursuit.

Given the sometimes rundown, poorly ventilated state of racetrack barns around the country, perhaps the most urgent one is this: How much of an impact do these conditions have on a horse's EIPH susceptibility?

There have been efforts to find answers, however, including a recent multi-state study designed primarily to gauge the prevalence and severity of post-race EIPH in 2-year-olds.

“This is certainly the largest study of 2-year-old horses that's been conducted,” said Dr. Warwick Bayly, dean of Washington State University's College of Veterinary Medicine and the lead researcher on the study, which took in video endoscopies of 893 2-year-olds after 1,071 races at 15 American racetracks.

The results of the endoscopies–taken between 30 to 60 minutes after the race–were then sent blind to a team of three observers who assigned an EIPH score of zero (none) to four (severe) to each.

Though these results are currently being spun into a peer-reviewed paper, Bayly shared some of the preliminary data with the TDN.

As a comparison between 2-year-olds that received Lasix and those that didn't, the study “unfortunately lacked sufficient statistical power” because the bulk of the horses scoped–roughly 83%–ran Lasix free, said Bayly.

Nevertheless, despite Bayly calling the results of the 2-year-old study “pretty homogenous,” the study has generated some conclusions of interest, including how:

  • EIPH was found in 66% of cases, with scores of three or four occurring in 8% of cases. The prevalence and severity of EIPH in 2-year-olds, therefore, was consistent with that of older racehorses.
  • The severity of EIPH appeared to vary with track location but not track surface–a trend, says Bayly, that warrants further investigation.

Bayly and his fellow researchers didn't just study 2-year-olds; stake-race performers aged three and older also formed a separate study group. From these results, Bayly draws a few conclusions of note.

As has been shown in other studies, more severe EIPH is linked to poor racetrack performance. The chances of severe EIPH also increased with race distance.

Another is that as horses age and accumulate more races and workouts, the severity of EIPH worsens. “If a 6-year-old is still running in stakes races, it's because it's a darn good horse,” he said.

Coady

Perhaps most interestingly, an episode of moderate to severe EIPH isn't necessarily predictive of an equally bad event next time the horse runs.

“A couple of horses that had a three or a four [grade EIPH], the next time they ran, they didn't have it–they might have been a one,” said Bayly. “Horses that were a grade two, subsequently their next run afterwards might have been a two or a one or a zero.”

Most pertinent for this story, the study also sought to determine whether various environmental factors predispose a racehorse to increased likelihood of EIPH.

The researchers are hoping to look at the Air Quality Index (AQI) at each location, the horse's bedding, the material of the horse's stall (wood or metal, for example), and whether that stall opened inwards into the barn or faced outwards.

Because of the migratory nature of racing, with horses routinely shipped from track to track, Bayly described the gathering of much of this information as rather catch-as-catch-can.

“We just didn't have the resources to really delve into that and I am not sure we will find anything, although horsemen are interested in the subject,” he said.

That last observation is on the money, as some industry stakeholders argue that the relationship between a horse's environment and EIPH is already clear.

Coady

Real-world application

“Our stalls at our racetracks are terrible,” said Bill Casner, former trainer and co-founder of WinStar Farm.

“If trainers would only have a high understanding of the implications of a poor respiratory environment on their horses, they could really go a long way in mitigating bleeding,” he added.

For years now, Casner has been on something of a crusade to raise industry awareness of the importance of a horse's environment to its respiratory health and overall athletic performance.

“I trained racehorses in my youth, and I couldn't shake out a straw stall,” he said, in explanation of what prompted this interest. “Straw would give me a severe asthma attack. That was where I really started to become aware.”

In 2016, Casner appeared at the Welfare and Safety of the Racehorse Summit at Keeneland, extolling the virtues of stalls and shedrows free of lung-clogging dust, pathogens and mold.

His presentation included an overview of his then relatively new bespoke training barn at WinStar Farm, in Kentucky, which he designed to address what he sees as the four central pillars of lung health: ventilation, bedding, forage and contamination.

A concrete and metal shell that's easy to clean with a power-wash, the WinStar barn is tall and airy to prevent ammonia collecting in the horse's immediate breathing space. Ammonia can irritate the respiratory tract in horses.

Indeed, unlike traditional stables with a loft overhead to store hay and straw, the horses sleep beneath a ceiling full of skylights and large fans to circulate the air without dredging up dust from the floor.

Visitors to the barn won't even find rafters where birds–what Casner describes as “just another vector” for disease and bacteria–can perch.

Hay is steamed and fed to the horses on the floor. Hay nets are anathema. Shavings and wood pellets are used to bed the horses down instead of straw.

And once a week, Casner “fogs” the stalls with a novel mixture made from a cationic steroid anti-microbial (CSA) liquid diluted in five gallons of water.

Casner swears that since routinely fogging the barns with the anti-microbial mist–a mixture that kills only the bad microbes, not the good–the coughs, sniffles, spiking temperatures and skin problems that typically rampage through a barn full of youngstock with their embryonic immune systems have been all but eliminated.

“I've been spraying it in my barn for gash-dang eight years now. Since then, we haven't had one cough and we haven't had one temp,” he said.

Ultimately, said Casner, “bleeding is an inflammatory issue.”

Coady

Environmental factors

The thing is, while researchers have identified an association between EIPH and inflammatory airway disease [IAD] in horses, a scientifically proven link “has not been published,” said Dr. Laurent Couetil, a professor of large animal medicine at Purdue University whose research has focused on inflammatory respiratory disease in horses, including racehorses.

“The big picture is that EIPH is very common in racehorses, as we know, as is mild asthma,” Couetil added, using another more everyday term for inflammatory airway disease.

“To just have those two things co-exist because they are common in their own right makes sense,” he added. “So, the question truly is: Are they linked?”

The first such potential association between EIPH and airway inflammation arrived in the late 1980s with a study on horses that had raced in Hong Kong and had suffered a bleeding event.

Through subsequent necropsies, pathologists found that in the same areas of the lungs most damaged though EIPH there existed an unusual amount of localized inflammation.

Since then, published research into IAD shows that the number one villain is probably dust and particulates in the air, with much of the literature reinforcing Casner's approach to clean, well-ventilated stables, along with dampened hay fed on the ground.

“Anything that really works to reducing dust exposure, especially the small dust particles, is exactly what should be done,” Couetil said, pointing to how fine particulates can trigger airway inflammation, while larger particulates worsen it.

Jen Roytz

“If you think about horses and their normal environment, their habitat should be outside on the prairies, grazing,” he added.

This study, for example, compared horses fed hay in nets to those fed hay on the floor.

Not only were the hay-net fed horses exposed to more dust and particulate matter than the floor-fed horses, but their lungs appeared to have significantly greater inflammation, too.

This leads to other potential connecting threads.

Horses kept in enclosed or dusty stables are more likely to exhibit visible mucus in the trachea, this study found. And as this prior study of Thoroughbreds determined, higher levels of tracheal mucus were linked to poor racing performance.

More than 10 years ago, a team of experts looked at the air quality throughout the day in three different barns at Thistledown Race Track over the months of July, September and November.

Among the key findings:

  • Enclosed, poorly ventilated stables had the dustiest air
  • The barn location of the stall dictated air quality
  • Air particulate concentrations were highest in September and November, lowest in July
  • The quality of the air was significantly worse in the morning than the rest of the day

Respiratory health isn't just an issue confined to the indoors, however.

Like Bayly with his ongoing multi-state study, researchers are looking at the potential impact that outdoor air quality might have on the equine athlete.

“I was doing some quick math and when a horse goes out to train or race, the amount of air they move in and out is similar to the rest of the day and the volume of air they breathe in when they are quiet,” said Couetil, adding that a horse's “ventilation” increases 30-fold during peak exercise.

The air surrounding inner-city tracks can be polluted with all sorts of contaminants like industrial chemicals and exhaust fumes, long-term exposures to which are known to cause severe human health issues. Are horses vulnerable to similar effects?

“If you race just a short amount of time in a polluted area, it might lead to a similar exposure to the rest of the day when they're quietly breathing in the stall,” Couetil explained. “Nobody has really looked at this–it's something that needs to be explored.”

In that vein, Couetil is involved in an ongoing two-year study to assess real-time dust exposures at four different tracks using a monitor attached to participating horses' halters. The study will simultaneously measure the pollution levels at each track.

Nevertheless, when it comes to the link most critical to horseracing–that between EIPH and inflammatory airway disease–there is “so much we don't know,” Couetil emphasized.

“We are kind of scratching the surface right now.”

The post From Dust to Dust: Do “Terrible” Racetrack Barns Exacerbate EIPH? appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

They Ran a Lasix Free Breeders’ Cup…And Nothing Happened

The biggest story when it comes to the ban of Lasix in the Breeders' Cup is that there was no story. It was, simply, a non-factor.

A total of 148 horses competed in this year's Breeders' Cup, all of them running Lasix-free. There were no reports of any horses being in distress or bleeding from the nostrils. I did not hear of one trainer blaming a defeat on the ban of the diuretic. Nor did I hear of or read about any trainers saying they were passing the Breeders' Cup because Lasix wasn't being allowed.

And there was a record handle, so, clearly the bettors weren't reluctant to play races without Lasix.

Dr. Jeff Blea, the equine medical director for the California Horse Racing Board, said that he hadn't seen any signs of serious or obvious problems.

“There was no informal data collected to evaluate EIPH in horses that ran on Friday and Saturday,” he said in an email.  “Anecdotally, I had surveyed several of the local attending veterinarians to get an understanding of what they were seeing endoscopically, specifically horses that bled a grade 3 or 4. I'm still waiting on responses from two practitioners, but it doesn't appear that it was a significant problem.

“One practitioner commented that grade 3/4 was noted in less than 10% of the horses he scoped. That said, I don't know his denominator. Others commented that they were surprised that they didn't observe severe episodes of EIPH. Furthermore, to my knowledge, I am not aware of any incidents of epistaxis on those two days.”

What happened to all the dire prognostications, that horsemen would suffer irreparable injury if the drug were taken away from them? That innumerable horses would no longer be able to race without it? That horses would bleed through the nostrils in full view of a horrified public? That it is inhumane to force horses to race without Lasix?

None of that has been proven to be true.

Lasix was banned on 2-year-olds in many jurisdictions in 2020. This year, it was also banned in graded stakes races at most of the top tier tracks. This year's Triple Crown was also contested Lasix-free, also without any problems. There is not much available so far in the way of data regarding how horses fared without Lasix, but, just as was the case with the Breeders' Cup, the number of serious problems appear to have been minimal. The sport simply adjusted and moved on.

By the time we got to the Breeders' Cup, the Lasix debate, once among the most controversial subjects in the game, had turned into a non-issue. Probably a lot of you never even took it into account that this Breeders' Cup would be contested without the diuretic. That's because the results of this year's Lasix-free races have proved that taking it away is, well, no big deal.

That's just it. Is Lasix really necessary? Trainers no longer give it just to bleeders but to every horse in their barn. It became a matter of not preventing bleeding but not allowing the competition to have an edge on you.

Racing is conducted everywhere else in the world without it and American racing had done just fine without it for one-hundred-plus years before its use became widespread in the 80s.

So why allow it? It's been evident for a long time that U.S. racing is too dependant on drugs, which has created an image problem for an industry that keeps on having to prove that it is on the level and that it is safe.

But my biggest problem with Lasix is that there is credible evidence that it is a major factor when it comes to why horses race so infrequently these days. In 1970, before Lasix had permeated racing's landscape, the average number of starts per runner per year was 10.22. It's now down to about 6.15.

The slide in the number of average starters per year began just about the same time that Lasix started being legalized across the country. That's not surprising since Lasix's is a diuretic that acts to dehydrate horses. When dehydrated, a race takes something extra out of a horse and they need more time to recover. That's just common sense.

That's anecdotal evidence that Lasix has contributed to a situation where we have the most unhealthy, least durable collection of horses ever seen in modern times.

The good news is that there are more changes on the horizon. When the Horseracing Safety and Integrity Act (HISA) goes into effect, the clock will start ticking on the drug. Under HISA, a racing commission that wants to prolong Lasix use can do so for three years. After the three-year period, a unanimous vote from HISA would be needed to continue the legal use of the drug. It's on its way out.

Yes, the sport has many problems that are a lot more serious than the use of Lasix. We've seen that with the rash of breakdowns at Santa Anita in 2019 and the 2020 indictments of trainers Jason Servis, Jorge Navarro and others on charges that they were using performance-enhancing drugs. That doesn't mean that the sport can't assess each issue independently and act. Getting rid of Lasix won't solve all the drug issues, but it's a step in the right direction and the right thing to do.

And horsemen, those who were predicting doomsday scenarios, can relax. They will do just fine without the drug. This year's Breeders' Cup proved just that.

The post They Ran a Lasix Free Breeders’ Cup…And Nothing Happened appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Trainers In Maryland Warned About Use Of Amicar

The Maryland Thoroughbred Horsemen's Association has released a statement regarding the use of anti-bleeding medications for racehorses in training. Horsemen are encouraged to stop the use of these drugs immediately, particularly the use of aminocaproic acid, sold under the name Amicar.

Amicar and other anti-bleeding medications are used to prevent bleeding from horses that suffer from Exercise Induced Pulmonary Hemorrhage (EIPH).

Amicar and multiple other anti-bleeding medications were placed on the Prohibited List in 2013 under Association of Racing Commissioners International Uniform Classification Guidelines for Foreign Substances.

These medications were placed on this list because they cannot be regulated by withdrawal time guidelines, and the medications have no timeline in which they can be used in which they might not trigger a positive test post-race.

Any trainer who uses these medications runs the risk of his or her horse coming back with a positive drug test post-race.

Read more here.

The post Trainers In Maryland Warned About Use Of Amicar appeared first on Horse Racing News | Paulick Report.

Source of original post

Verified by MonsterInsights